A Multicenter Phase II Study of Docetaxel in Combination with Gefitinib in Gemcitabine-Pretreated Patients with Advanced/Metastatic Pancreatic Cancer

Publisher： Karger

E-ISSN： 1423-0232|71|3-4|159-163

ISSN： 0030-2414

Source： Oncology, Vol.71, Iss.3-4, 2007-07, pp. : 159-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of Docetaxel and Gefitinib as Second-Line Therapy in Gemcitabine Pretreated Patients with Advanced Pancreatic Cancer

By  

Oncology, Vol. 76, Iss. 4, 2009-03 ,pp. : 270-274

Karger

Access to resources Recommend Favorite

Salvage Chemotherapy with Gemcitabine and Oxaliplatin in Heavily Pretreated Patients with Metastatic Breast Cancer: A Multicenter Phase II Study

By  

Oncology, Vol. 70, Iss. 4, 2006-10 ,pp. : 273-279

Karger

Access to resources Recommend Favorite

Phase II Study of Gemcitabine in Combination with Docetaxel in Patients with Advanced Pancreatic Carcinoma (E1298)

By  

Oncology, Vol. 66, Iss. 4, 2004-06 ,pp. : 303-309

Karger

Access to resources Recommend Favorite

Oral Capecitabine in Gemcitabine-Pretreated Patients with Advanced Pancreatic Cancer

By  

Oncology, Vol. 73, Iss. 3-4, 2008-04 ,pp. : 221-227

Karger

Access to resources Recommend Favorite

Front-Line Chemotherapy with Docetaxel and Gemcitabine Administered Every Two Weeks in Patients with Metastatic Breast Cancer: A Multicenter Phase II Study

By  

Oncology, Vol. 67, Iss. 3-4, 2004-11 ,pp. : 250-256

Karger

Access to resources Recommend Favorite